New Molecules

  • Placeholder
    API

    Semaglutide(for oral)

    CAS:910463-68-2

  • auto draft
    API

    Sermelanotide

    CAS:920014-72-8
    Status:R&D
    Indications:Endocrine, nutritional, and metabolic diseases
  • Placeholder
    ADC

    SG3199

  • Placeholder
    ADC

    SN-38

  • Placeholder
  • somatostatin
    API

    Somatostatin

    CAS:51110-01-1
    Status:CEP, NMPA, WC
    Indications:Digestive System Diseases
  • auto draft
    API

    Survodutide

    CAS:2805997-46-8
    Status:R&D
    Indications:Diseases of the circulatory system
  • Placeholder
  • teriparatide
    API

    Teriparatide

    CAS:99294-94-7
    Status:DMF, NMPA
    Indications:Musculoskeletal system and connective tissue diseases
  • auto draft
    API

    Terlipressin

    CAS:14636-12-5
    Status:CEP, NMPA, WC
    Indications:Diseases of the digestive system and diseases of the urogenital system
  • auto draft
    API

    Thymalfasin

    CAS:69521-94-4
    Status:NMPA
    Indications:Certain infectious and parasitic diseases
  • auto draft
    API

    Thymopentin

    CAS:69558-55-0
    Status:NMPA
    Indications:Certain infectious and parasitic diseases, as well as factors affecting health status
Scroll to Top